Association Between Dose Dialysis by Kt and Mortality

Completed

• Conditions: End Stage Renal Disease; Hemodialysis Patients

• Registration Number: NCT01932853
• Lead Sponsor: NephroCare Spain

Brief Summary

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-08-27
• Study First Submitted QC: 2013-08-27
• Study First Posted: 2013-08-30
• Study Start: 2013-10
• Primary Completion: 2013-12
• Status Verified: 2015-10
• Study Completion: 2015-12
• Last Update Submitted: 2016-07-12
• Last Update Posted: 2016-07-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6129

Inclusion Criteria

• > 18 years old
• > six months on hemodialysis
• Receiving 3 sessions of dialysis per week
• Having 5 or more valid measures of Kt during the month

Exclusion Criteria

• active chronic inflammatory diseases
• Liver cirrhosis
• Neoplasms
• Chronic immunosuppression or use of anti-inflammatory

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	two years

Secondary Outcome Measures

Name	Time	Method
Hospitalization	two years

Trial Locations

Locations (1)

NephroCare Spain; 🇪🇸 Madrid, Spain